Page last updated: 2024-08-16

su 4984 and su 5402

su 4984 has been researched along with su 5402 in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (50.00)18.2507
2000's2 (33.33)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hirth, P; Hubbard, SR; McMahon, G; Mohammadi, M; Schlessinger, J; Sun, L; Tang, C; Yeh, BK1
App, H; Hirth, P; McMahon, G; Sun, L; Tang, C; Tang, F; Tran, N1
Coutinho, EC; Jaggi, M; Karia, D; Loriya, R; Manvar, A; Mukherjee, R; Shah, A; Shaikh, MS; Singh, A; Upadhyay, K; Virsodia, V1
Cheng, W; Tian, X; Wang, M; Zhang, X1
Elbaum, D; Lydon, NB; Toledo, LM1
Carter, E; Longley, BJ; Ma, Y; McMahon, G1

Reviews

3 review(s) available for su 4984 and su 5402

ArticleYear
An overview of the binding models of FGFR tyrosine kinases in complex with small molecule inhibitors.
    European journal of medicinal chemistry, 2017, Jan-27, Volume: 126

    Topics: Humans; Protein Binding; Protein Kinase Inhibitors; Receptor Protein-Tyrosine Kinases; Small Molecule Libraries

2017
The structure-based design of ATP-site directed protein kinase inhibitors.
    Current medicinal chemistry, 1999, Volume: 6, Issue:9

    Topics: Adenosine Triphosphate; Adenylyl Imidodiphosphate; Anthraquinones; Binding Sites; Catalytic Domain; Cyclin-Dependent Kinases; Drug Design; Enzyme Inhibitors; Humans; Kinetin; Piperazines; Protein-Tyrosine Kinases; Purines; Pyridines; Pyrimidines; Pyrroles; Quinazolines; Receptors, Growth Factor; Roscovitine; Staurosporine; Structure-Activity Relationship

1999
New approaches to therapy for mastocytosis. A case for treatment with kit kinase inhibitors.
    Hematology/oncology clinics of North America, 2000, Volume: 14, Issue:3

    Topics: Amino Acid Substitution; Combined Modality Therapy; Drug Design; Enzyme Activation; Enzyme Inhibitors; Feasibility Studies; Humans; Indoles; Ligands; Mast Cells; Mastocytosis; Piperazines; Point Mutation; Proto-Oncogene Proteins c-kit; Proto-Oncogenes; Pyrroles; Stem Cell Factor

2000

Other Studies

3 other study(ies) available for su 4984 and su 5402

ArticleYear
Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors.
    Science (New York, N.Y.), 1997, May-09, Volume: 276, Issue:5314

    Topics: 3T3 Cells; Adenosine Triphosphate; Amino Acid Sequence; Animals; Crystallography, X-Ray; Enzyme Inhibitors; ErbB Receptors; Hydrogen Bonding; Mice; Models, Molecular; Phosphorylation; Phosphotyrosine; Piperazines; Protein-Tyrosine Kinases; Pyrroles; Receptor Protein-Tyrosine Kinases; Receptor, Fibroblast Growth Factor, Type 1; Receptor, Insulin; Receptors, Fibroblast Growth Factor; Receptors, Platelet-Derived Growth Factor

1997
Synthesis and biological evaluations of 3-substituted indolin-2-ones: a novel class of tyrosine kinase inhibitors that exhibit selectivity toward particular receptor tyrosine kinases.
    Journal of medicinal chemistry, 1998, Jul-02, Volume: 41, Issue:14

    Topics: Cells, Cultured; Enzyme Inhibitors; ErbB Receptors; Humans; Indoles; Magnetic Resonance Spectroscopy; Phosphorylation; Protein-Tyrosine Kinases; Receptor Protein-Tyrosine Kinases; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Growth Factor; Receptors, Platelet-Derived Growth Factor; Receptors, Vascular Endothelial Growth Factor; Stereoisomerism; Structure-Activity Relationship

1998
Synthesis of 1-(2,6-dichlorophenyl)-3-methylene-1,3-dihydro-indol-2-one derivatives and in vitro anticancer evaluation against SW620 colon cancer cell line.
    European journal of medicinal chemistry, 2009, Volume: 44, Issue:3

    Topics: Antineoplastic Agents; Cell Line, Tumor; Colonic Neoplasms; Drug Screening Assays, Antitumor; Humans; Indoles; Magnetic Resonance Spectroscopy; Quantitative Structure-Activity Relationship; Spectrometry, Mass, Fast Atom Bombardment; Spectrophotometry, Infrared

2009